Careers & Workforce Trends

Recruiting, compensation, telework, and new care team models in clinics/hospitals.

  • 3 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Careers & Workforce Trends


fbcnews.com.fj > news > fma-calls-for-urgent-workforce-planning

FMA calls for urgent workforce planning

6+ hour, 22+ min ago   (362+ words) The Fiji Medical Association is calling for stronger action to address workforce shortages, healthcare resources, and the growing challenges facing Fiji’s health system. The call was made during the opening of the Fiji Medical Association’s 2026 Annual Scientific Conference. FMA President…...


finance.yahoo.com > healthcare > articles > definium-reports-second-phase-iii-141600164.html

Definium Reports Second Phase III Success in Anxiety Disorder Program

3+ hour, 41+ min ago   (353+ words) Year to date, Definium stock has skyrocketed 200.6% against the industry's 2.9% decline. Beyond GAD, Definium is advancing DT120 ODT in major depressive disorder (MDD). DFTX's phase III Emerge study delivered positive top-line results in June 2026, meeting its primary and key secondary endpoints. The…...


cyprus-mail.com

Third complaint filed against Larnaca medical centre

6+ hour, 5+ min ago   (315+ words) A third complaint against a Larnaca medical centre offering plasmapheresis treatment was filed by the health ministry on Tuesday following an on-site inspection on Friday. Speaking to the Cyprus Mail, the ministry confirmed that two previous complaints concerning the same…...


clinicaltrialvanguard.com > news > definiums-dt120-odt-meets-primary-endpoint-in-phase-3-gad-study

Definium’s DT120 ODT Meets Primary Endpoint in Phase 3 GAD Study

11+ hour, 18+ min ago   (321+ words) clinicaltrialvanguard.com Definium’s DT120 ODT Meets Primary Endpoint in Phase 3 GAD Study Definium Therapeutics reported positive topline data from its Phase 3 Panorama study of DT120 ODT in generalized anxiety disorder on September 14, 2026, a result that matters because GAD pharmacotherapy has run on…...


medium.com > @topcbdnewz8 > https-www-facebook-com-groups-vigortrixmaleenhancementpills-abb9fa7cf2d0

https://www.facebook.com/groups/vigortrixmaleenhancementpills/ | by Topcbdnewz | Sep, 2026

19+ hour ago   (35+ words) ╰┈➤ Product Name:⇢ Vigortrix Male Enhancement ╰┈➤ Benefits:⇢ Improve Testosterone Level and Libido ╰┈➤ Availability:⇢ In Stock Voted #1 Product in the USA What is Vigortrix Male Enhancement? ➲➲➲ Sale Is Live At Official Website ➾➾ Hurry Up Visit NOW...


newindianexpress.com > states > tamil-nadu > 09/13/2026 > tn-youth-loses-hand-after-negligent-treatment-at-siddha-centre

TN youth loses hand after negligent treatment at Siddha centre

2+ day, 14+ hour ago   (266+ words) DHARMAPURI: The Pennagaram police registered a case against two people at a Siddha Bone Setting centre for administering wrong treatment that caused a 24-year-old youth to lose his hand. The Pennagaram police registered a case against Kadirvel (48), administrator of Perumal…...


hyderabadmail.com > apollo-hospital-medical-negligence-stroke-treatment-telangana-consumer-commission

Apollo Hospital faces ₹43 lakh compensation order over stroke patient’s death

2+ day, 14+ hour ago   (393+ words) HYDERABAD: The Telangana State Consumer Disputes Redressal Commission has held Apollo Hospital Enterprises Ltd liable for medical negligence in the treatment of a patient who suffered an acute ischemic stroke in March 2013. In its judgment in CC No. 116 of 2015, the…...


surinenglish.com > spain > family-young-woman-20260910000500-nt.html

Family of young woman left in vegetative state after anaphylactic shock reject 100,000-euro compensation payout

5+ day, 6+ hour ago   (377+ words) The family have been claiming 4.1 million euros for what they describe as "inadequate" medical examination and care. In a video on social media, they said that they would continue fighting for a fair compensation. "It's a disgrace if they think…...


biospace.com > fda > opinion-for-pdufa-viii-the-most-valuable-incentive-may-be-time

For PDUFA VIII, the most valuable incentive may be time

5+ day, 13+ hour ago   (506+ words) For a small biotech, the more practical incentive is time. Speed matters—whether a drug succeeds or fails. Finding out earlier that the biology is wrong stops further investment, limits unnecessary exposure of patients and allows scientists and resources to…...